Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial
ConclusionBZRA prevalence was high among included multimorbid older adults, and BZRA cessation occurred in almost a quarter of them within 6 months after hospitalization. Targeted BZRA deprescribing programs could further enhance cessation. Specific attention is needed for females, central nervous system-acting co-medication, and COPD co-morbidity.RegistrationClinicalTrials.gov identifier: NCT02986425. December 8, 2016.
Source: Drugs and Aging - Category: Geriatrics Source Type: research
More News: Anxiety | Chronic Obstructive Pulmonary | Depression | Diabetes | Endocrinology | Geriatrics